Supernus Pharmaceuticals, Inc. (SUPN)
37.88
-1.69
(-4.27%)
USD |
NASDAQ |
Oct 16, 16:00
37.86
-0.02
(-0.05%)
After-Hours: 20:00
Supernus Pharmaceuticals Cash from Investing (Quarterly) : 7.094M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.094M |
| March 31, 2026 | -19.22M |
| December 31, 2025 | -51.31M |
| September 30, 2025 | 48.71M |
| June 30, 2025 | -30.61M |
| March 31, 2025 | 37.32M |
| December 31, 2024 | -12.64M |
| September 30, 2024 | -77.01M |
| June 30, 2024 | -48.59M |
| March 31, 2024 | -51.62M |
| December 31, 2023 | -65.98M |
| September 30, 2023 | 34.63M |
| June 30, 2023 | 60.30M |
| March 31, 2023 | 239.78M |
| December 31, 2022 | -48.76M |
| September 30, 2022 | -82.23M |
| June 30, 2022 | -15.68M |
| March 31, 2022 | -69.99M |
| December 31, 2021 | 76.13M |
| September 30, 2021 | -5.704M |
| June 30, 2021 | -80.89M |
| March 31, 2021 | -71.44M |
| December 31, 2020 | 49.34M |
| September 30, 2020 | -11.30M |
| June 30, 2020 | -108.18M |
| Date | Value |
|---|---|
| March 31, 2020 | 35.44M |
| December 31, 2019 | 19.44M |
| September 30, 2019 | -8.355M |
| June 30, 2019 | -65.76M |
| March 31, 2019 | -103.25M |
| December 31, 2018 | 34.33M |
| September 30, 2018 | 25.34M |
| June 30, 2018 | -422.14M |
| March 31, 2018 | -51.01M |
| December 31, 2017 | -19.13M |
| September 30, 2017 | -21.16M |
| June 30, 2017 | -25.36M |
| March 31, 2017 | -20.76M |
| December 31, 2016 | -13.64M |
| September 30, 2016 | -10.35M |
| June 30, 2016 | -1.322M |
| March 31, 2016 | -10.65M |
| December 31, 2015 | -15.93M |
| September 30, 2015 | -5.698M |
| June 30, 2015 | -6.54M |
| March 31, 2015 | -11.12M |
| December 31, 2014 | -8.684M |
| September 30, 2014 | -0.973M |
| June 30, 2014 | 6.399M |
| March 31, 2014 | -1.629M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Indivior Pharmaceuticals, Inc. | -7.942M |
| Prestige Consumer Healthcare, Inc. | -1.064B |
| Pfizer Inc. | 2.106B |
| Amphastar Pharmaceuticals, Inc. | 44.87M |
| Bristol Myers Squibb Co. | -1.614B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.81M |
| Cash from Financing (Quarterly) | -7.20M |
| Free Cash Flow | 18.79M |
| Free Cash Flow Per Share (Quarterly) | -0.0926 |
| Free Cash Flow to Equity (Quarterly) | -4.645M |
| Free Cash Flow to Firm (Quarterly) | -3.034M |
| Free Cash Flow Yield | 0.86% |